List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 17 studies with search of: "Rasburicase"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Rasburicase in Patients at Risk for Tumor Lysis Syndrome
Condition: Tumor Lysis Syndrome
Intervention: Drug: Rasburicase
2 Recruiting Rasburicase to Prevent Acute Kidney Injury Following Cardiac Surgery
Condition: Hyperuricemia
Interventions: Drug: Rasburicase;   Drug: Placebo
3 Completed Rasburicase for Hyperuricemia
Condition: Nutritional and Metabolic Diseases
Intervention: Drug: rasburicase (SR29142)
4 Completed Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma
Conditions: Hyperuricemia;   Leukemia;   Lymphoma
Intervention: Drug: Rasburicase (SR29142)
5 Terminated Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma
Condition: Hyperuricemia
Intervention: Drug: Rasburicase (SR29142)
6 Completed Fasturtec TLS Treatment / Prophylysis
Condition: Tumor Lysis Syndrome
Intervention: Drug: urate oxidase
7 Completed Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy
Conditions: Tumors;   Hyperuricemia;   Tumor Lysis Syndrome
Intervention: Drug: Rasburicase (SR29142)
8 Recruiting Rasburicase (Fasturtec) Registration Trial
Condition: Hyperuricemia
Interventions: Drug: Rasburicase;   Drug: Allopurinol
9 Completed Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS
Conditions: Leukemia;   Lymphoma;   Tumor Lysis Syndrome
Intervention: Drug: Rasburicase
10 Completed Rasburicase in Tumor Lysis Syndrome
Condition: Hyperuricemia
Intervention: Drug: Rasburicase
11 Recruiting Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
Conditions: Leukemia;   Lymphoma;   Tumor Lysis Syndrome;   Hyperuricemia
Intervention: Drug: Rasburicase
12 Completed Study of Rasburicase Versus Allopurinol in Patients With Leukemia, Lymphoma, or Solid Tumor Malignancy at Risk for Hyperuricemia and Tumor Lysis Syndrome
Conditions: Tumor Lysis Syndrome;   Cancer;   Hyperuricemia
Interventions: Drug: Rasburicase;   Drug: Allopurinol
13 Recruiting Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
Conditions: Chronic Myeloproliferative Disorders;   Graft Versus Host Disease;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: etoposide;   Drug: methotrexate;   Drug: rasburicase;   Drug: sirolimus;   Drug: tacrolimus;   Other: flow cytometry;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: total-body irradiation
14 Completed Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome
Condition: Hyperuricemia
Intervention: Drug: Rasburicase
15 Recruiting Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma
Conditions: Adult Acute Lymphocytic Leukemia;   High-Grade Lymphoma
Interventions: Drug: Allopurinol;   Drug: Rasburicase
16 Suspended Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
Conditions: Cancer-Related Problem/Condition;   Leukemia;   Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: prednisone;   Drug: rasburicase;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate
17 Recruiting Pegylated Recombinant Mammalian Uricase (PEG-Uricase) as Treatment for Refractory Gout
Condition: Gout
Intervention: Biological: Pegloticase

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services